Genotyping of Chimerical BCR-ABL1 RNA in Chronic Myeloid Leukemia by Integrated DNA Chip

Authors: Kang, Jong-Hun, Goh, Hyun-Gyung, Chae, Sang-Ho, Kim, Sung-Yong, Kim, Dong-Wook, Chae, Chi-Bom

Source: In The Journal of Molecular Diagnostics September 2012 14(5):487-493

Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA

Authors: White, Helen E., Matejtschuk, Paul, Rigsby, Peter, Gabert, Jean, Lin, Feng, Lynn Wang, Y., Branford, Susan, Müller, Martin C., Beaufils, Nathalie, Beillard, Emmanuel, Colomer, Dolors, Dvorakova, Dana, Ehrencrona, Hans, Goh, Hyun-Gyung, El Housni, Hakim, Jones, Dan, Kairisto, Veli, Kamel-Reid, Suzanne, Kim, Dong-Wook, Langabeer, Stephen, Ma, Edmond S.K., Press, Richard D., Romeo, Giuliana, Wang, Lihui, Zoi, Katerina, Hughes, Timothy, Saglio, Giuseppe, Hochhaus, Andreas, Goldman, John M., Metcalfe, Paul ^*, Cross, Nicholas C.P. ^*

Source: In Blood 25 November 2010 116(22):e111-e117

Chronic myeloid leukemia in the Asia-Pacific region: Current practice, challenges and opportunities in the targeted therapy era

Authors: Kim, Dong-Wook, Banavali, Shripad D., Bunworasate, Udomsak, Goh, Yeow-Tee, Ganly, Peter, Huang, He, Irving, Ian, Jootar, Saengsuree, Goh, Hyun-Gyung, Koh, Liang-Piu, Li, Wei, Naoe, Tomoki, Ng, Soo-Chin, Purushotaman, Visalachy, Reksodiputro, Harryanto, Shih, Lee-Yung, Tang, Jih-Luh, Tojo, Arinobu, Wang, Jianmin, Wong, Raymond

Source: In Leukemia Research 2010 34(11):1459-1471

Structural modeling of V299L and E459K Bcr-Abl mutation, and sequential therapy of tyrosine kinase inhibitors for the compound mutations

Authors: Kim, Dongho, Kim, Dong-Wook, Cho, Byung-Sik, Goh, Hyun-Gyung, Kim, Soo-Hyun, Kim, Wan-Seok, Lee, Jeong, Kweon, Il-Young, Park, Sa-Hee, Yoon, Jeong Hyeok, Kim, Nam Doo, Chun, Haarin

Source: In Leukemia Research 2009 33(9):1260-1265

Comparative analysis of cell surface proteins in chronic and acute leukemia cell lines

Authors: Lee, Soo Jae, Kim, Kyun-Hwan, Park, Ji Sook, Jung, Jin Woo, Kim, Young Hwan, Kim, Sang Kyung, Kim, Wan-Seok, Goh, Hyun-gyung, Kim, Soo-hyun, Yoo, Jung-Sun, Kim, Dong-Wook, Kim, Kwang Pyo

Source: In Biochemical and Biophysical Research Communications 2007 357(3):620-626

Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR

Authors: Goh, Hyun-Gyung, Hwang, Ji-Yeon, Kim, Soo-Hyun, Lee, Young-Hoon, Kim, Yoo-Li, Kim, Dong-Wook

Source: In Translational Research 2006 148(5):249-256

Early prediction of molecular remission by monitoring BCR-ABL transcript levels in patients achieving a complete cytogenetic response after imatinib therapy for posttransplantation chronic myelogenous leukemia relapse

Authors: Kim, Yoo-Jin, Kim, Dong-Wook ^*, Lee, Seok, Min, Chang-Ki, Goh, Hyun-Gyung, Kim, Su-Hyun, Lee, Ji-Young, Kim, Yoo-Li, Kim, Hee-Je, Kim, Hyeoung-Jun, Lee, Jong-Wook, Kim, Tai-Gyu, Min, Woo-Sung, Kim, Chun-Choo

Source: In Biology of Blood and Marrow Transplantation 2004 10(10):718-725

Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay.

Authors: Goh, Hyun-Gyung¹ (AUTHOR), Lin, Min² (AUTHOR), Fukushima, Takashi³ (AUTHOR), Saglio, Giuseppe⁴ (AUTHOR), Kim, Dongho¹ (AUTHOR), Choi, Soo-Young¹ (AUTHOR), Kim, Soo-Hyun¹ (AUTHOR), Lee, Jeong¹ (AUTHOR), Lee, Young-Seok¹ (AUTHOR), Oh, Sang-Mi¹ (AUTHOR), Kim, Dong-Wook¹ (AUTHOR) dwkim@catholic.ac.kr

Source: Leukemia & Lymphoma. May2011, Vol. 52 Issue 5, p896-904. 9p. 4 Charts, 4 Graphs.

Subject Terms: *CHRONIC myeloid leukemia, *POLYMERASE chain reaction, *NANOFLUIDS, *CELL lines, *PROTEIN-tyrosine kinases

Previous best responses can be re-achieved by resumption after imatinib discontinuation in patients with chronic myeloid leukemia: implication for intermittent imatinib therapy.

Authors: Goh, Hyun-Gyung¹ (AUTHOR), Kim, Yoo-Jin² (AUTHOR), Kim, Dong-Wook^1,2 (AUTHOR) dwkim@catholic.ac.kr, Kim, Hyeoung-Joon³ (AUTHOR), Kim, Soo-Hyun¹ (AUTHOR), Jang, Se-Eun¹ (AUTHOR), Lee, Jeong¹ (AUTHOR), Kim, Dongho¹ (AUTHOR), Kim, Wan-Seok¹ (AUTHOR), Park, Sa-Hee¹ (AUTHOR), Kweon, Il-Young¹ (AUTHOR)

Source: Leukemia & Lymphoma. Jun2009, Vol. 50 Issue 6, p944-951. 8p. 1 Diagram, 3 Charts, 1 Graph.

Subject Terms: *IMATINIB, *ANTINEOPLASTIC agents, *CHRONIC myeloid leukemia, *LEUKEMIA treatment, *MYELOID leukemia, *HEALTH outcome assessment, *MEDICAL research

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Efficacy of Nilotinib Versus High-Dose Imatinib in Early Chronic Phase CML Patients Who Have Suboptimal Molecular Responses to Standard-Dose Imatinib (RE-NICE Multicenter Study)

Authors: Goh, Hyun-Gyung ^*, Jootar, Saengsuree, Kim, Hyeoung-Joon, Sohn, Sang Kyun ^*, Park, Joon Seong ^*, Kim, Sung Hyun, Zang, Dae Young ^*, Oh, Suk-Joong ^*, Choi, Soo-Young ^*, Bang, Ju-Hee ^*, Kim, Soo-Hyun ^*, Jang, Eun-Jung ^*, Lee, Sung-Eun ^*, Kim, Dongho ^*, Byeun, Ji-Young ^*, Woodman, Richard C., Szczudlo, Tomasz, Kim, Hee Jung ^*, Kim, Dong-Wook

Source: In Blood 18 November 2011 118(21):2765-2765

Correlation of Molecular Response At 18 Month with Survival Benefits As Response-Related Prognostic Factor

Authors: Kim, Soo-Hyun ^*, Kim, Dongho ^*, Goh, Hyun-Gyung ^*, Choi, Soo-Young ^*, Bang, Ju-Hee ^*, Byeun, Ji-Young ^*, Kim, Dong-Wook

Source: In Blood 18 November 2011 118(21):2766-2766

Discontinuation of Imatinib Therapy in Chronic Myeloid Leukemia Patients with Sustained Complete Molecular Response4.5 (CMR4.5)

Authors: Goh, Hyun-Gyung ^*, Choi, Soo-Young ^*, Bang, Ju-Hee ^*, Kim, Soo-Hyun ^*, Jang, Eun-Jung ^*, Kim, Dongho ^*, Byeun, Ji-Young ^*, Park, Joon Seong ^*, Kim, Hyeoung-Joon, Kim, Hawk, Kim, Dong-Wook

Source: In Blood 18 November 2011 118(21):2763-2763

Dynamics and Characteristics of BCR-ABL Multiple Mutations In Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia.

Authors: Kim, Dong-Wook, Kim, Dongho ^*, Kim, Soo-Hyun ^*, Jootar, Saengsuree, Goh, Hyun-Gyung ^*, Lee, Jeong ^*, Choi, Soo-Young ^*, Lee, Young-Seok ^*, Oh, Sang-Mi ^*

Source: In Blood 19 November 2010 116(21):3443-3443

Mutation Analysis of BCR-ABL Tyrosine Kinase Domain In New Chronic Phase-Chronic Myeloid Leukemia Patients with Suboptimal Response or Treatment Failure From Imatinib Treatment.

Authors: Kim, Dong-Wook, Kim, Dongho ^*, Kim, Soo-Hyun ^*, Goh, Hyun-Gyung ^*, Pane, Fabrizio ^*, Hughes, Timothy, Radich, Jerald P. ^*, Lin, Peter ^*, Saglio, Giuseppe, Branford, Susan, Martinelli, Giovanni, Soverini, Simona ^*, Hochhaus, Andreas

Source: In Blood 19 November 2010 116(21):3441-3441

Monitoring of Dynamics of BCR-ABL Transcripts Over Time Using Digital PCR Assay In CP CML Patients After Achieving Complete Molecular Remission

Authors: Goh, Hyun-Gyung ^*, Kim, Dongho ^*, Choi, Soo-Young ^*, Kim, Soo-Hyun ^*, Lee, Jeong ^*, Lee, Young-Seok ^*, Oh, Sang-Mi ^*, Kim, Dong-Wook

Source: In Blood 19 November 2010 116(21):1726-1726